Fulgent Income Before Tax from 2010 to 2024
| FLGT Stock | USD 21.14 0.21 0.98% |
Income Before Tax | First Reported 2015-03-31 | Previous Quarter -145.2 M | Current Value -14.2 M | Quarterly Volatility 79 M |
Check Fulgent Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fulgent main balance sheet or income statement drivers, such as Discontinued Operations of 49.5 K, Depreciation And Amortization of 33.3 M or Interest Expense of 38.9 M, as well as many exotic indicators such as Price To Sales Ratio of 2.83, Dividend Yield of 0.0186 or PTB Ratio of 0.72. Fulgent financial statements analysis is a perfect complement when working with Fulgent Genetics Valuation or Volatility modules.
Fulgent | Income Before Tax |
Latest Fulgent Genetics' Income Before Tax Growth Pattern
Below is the plot of the Income Before Tax of Fulgent Genetics over the last few years. Income Before Tax which can also be referred as pre-tax income is reported on Fulgent Genetics income statement and is an important metric when analyzing Fulgent Genetics profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability. It is Fulgent Genetics' Income Before Tax historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fulgent Genetics' overall financial position and show how it may be relating to other accounts over time.
| Income Before Tax | 10 Years Trend |
|
Income Before Tax |
| Timeline |
Fulgent Income Before Tax Regression Statistics
| Arithmetic Mean | 14,603,083 | |
| Coefficient Of Variation | 785.84 | |
| Mean Deviation | 71,498,500 | |
| Median | (990,000) | |
| Standard Deviation | 114,757,131 | |
| Sample Variance | 13169.2T | |
| Range | 465.8M | |
| R-Value | 0.01 | |
| Mean Square Error | 14181.6T | |
| R-Squared | 0.000041 | |
| Significance | 0.98 | |
| Slope | 163,360 | |
| Total Sum of Squares | 184368.8T |
Fulgent Income Before Tax History
About Fulgent Genetics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Fulgent Genetics income statement, its balance sheet, and the statement of cash flows. Fulgent Genetics investors use historical funamental indicators, such as Fulgent Genetics's Income Before Tax, to determine how well the company is positioned to perform in the future. Although Fulgent Genetics investors may use each financial statement separately, they are all related. The changes in Fulgent Genetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fulgent Genetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fulgent Genetics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fulgent Genetics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Income Before Tax | -174.1 M | -165.4 M |
Pair Trading with Fulgent Genetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fulgent Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fulgent Genetics will appreciate offsetting losses from the drop in the long position's value.Moving together with Fulgent Stock
| 0.64 | DOCS | Doximity | PairCorr |
| 0.61 | VEEV | Veeva Systems Class Earnings Call This Week | PairCorr |
| 0.7 | ENSG | Ensign Group | PairCorr |
Moving against Fulgent Stock
| 0.67 | GCTK | GlucoTrack | PairCorr |
| 0.55 | EHC | Encompass Health Corp | PairCorr |
The ability to find closely correlated positions to Fulgent Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fulgent Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fulgent Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fulgent Genetics to buy it.
The correlation of Fulgent Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fulgent Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fulgent Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fulgent Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Fulgent Genetics Correlation against competitors. For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.Note that the Fulgent Genetics information on this page should be used as a complementary analysis to other Fulgent Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Fulgent Stock analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Fulgent Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulgent Genetics. If investors know Fulgent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share (5.56) | Revenue Per Share 9.635 | Quarterly Revenue Growth (0.03) | Return On Assets (0.03) |
The market value of Fulgent Genetics is measured differently than its book value, which is the value of Fulgent that is recorded on the company's balance sheet. Investors also form their own opinion of Fulgent Genetics' value that differs from its market value or its book value, called intrinsic value, which is Fulgent Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulgent Genetics' market value can be influenced by many factors that don't directly affect Fulgent Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulgent Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.